Characteristics and Outcomes of Anti-interferon Gamma Antibody-Associated Adult Onset Immunodeficiency

Höflich C, Sabat R, Rosseau S, Temmesfeld B, Slevogt H, Döcke W, et al. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood. 2004;103:673–5.

Article  PubMed  Google Scholar 

Döffinger R, Helbert M, Barcenas-Morales G, Yang K, Dupuis S, Ceron-Gutierrez L, et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis. 2004;38:e10-14.

Article  PubMed  Google Scholar 

Lin C, Chi C, Shih H, Ding J, Lo C, Wang S, et al. Identification of a major epitope by anti-interferon-γ autoantibodies in patients with mycobacterial disease. Nat Med. 2016;22:994–1001.

Article  CAS  PubMed  Google Scholar 

Browne S, Zaman R, Sampaio E, Jutivorakool K, Rosen L, Ding L, et al. Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection. Blood. 2012;119:3933–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen ZM, Yang XY, Li ZT, Guan WJ, Qiu Y, Li SQ, et al. Anti-interferon-gamma autoantibodies impair T-lymphocyte responses in patients with Talaromyces marneffei infections. Infect Drug Resist. 2022;15:3381–93.

Article  PubMed  PubMed Central  Google Scholar 

Browne S, Burbelo P, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw P, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Eng J Med. 2012;367:725–34.

Article  CAS  Google Scholar 

Wu U, Hung C, Chang S, Jhong Y, Sun H, Wang J, et al. Neutralizing antiinterferon-γ autoantibodies causing disseminated Mycobacterium avium complex infection in an HIV-infected patient on successful combination antiretroviral therapy. AIDS. 2017;31:2557–9.

Article  CAS  PubMed  Google Scholar 

Hong G, Ortega-Villa A, Hunsberger S, Chetchotisakd P, Anunnatsiri S, Mootsikapun P, et al. Natural history and evolution of anti-interferon-γ autoantibody-associated immunodeficiency syndrome in Thailand and the United States. Clin Infect Dis. 2020;71:53–62.

Article  CAS  PubMed  Google Scholar 

Ku CL, Lin CH, Chang SW, Chu CC, Chan JF, Kong XF, et al. Anti-IFN-gamma autoantibodies are strongly associated with HLA-DR*15:02/16:02 and HLA-DQ*05:01/05:02 across Southeast Asia. J Allergy Clin Immunol. 2016;137(945–948):e948.

Google Scholar 

Chi C, Chu C, Liu J, Lin C, Ho M, Lo W, et al. Anti-IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. Blood. 2013;121:1357–66.

Article  CAS  PubMed  Google Scholar 

Oka K, Yamane M, Yokota Y, Yasuda M, Hasegawa K, Fujimori T, et al. Disseminated Mycobacterium genavense infection mimicking TAFRO syndrome. J Infect Chemother. 2020;26:1095–9.

Article  CAS  PubMed  Google Scholar 

King Y, Hu C, Lee Y, Lin C, Liu D, Wang K. Disseminated cutaneous Mycobacterium kansasii infection presenting with Rosai-Dorfman disease-like histological features in a patient carrying anti-interferon-γ autoantibodies. J Dermatol. 2017;44:1396–400.

Article  CAS  PubMed  Google Scholar 

Furuya H, Ikeda K, Miyachi K, Nakamura K, Suzuki K, Furuta S, et al. SAPHO syndrome-like presentation of disseminated nontuberculous mycobacterial infection in a case with neutralizing anti-IFNγ autoantibody. Rheumatology. 2017;56:1241–3.

Article  PubMed  Google Scholar 

Koizumi Y, Sakagami T, Minamiguchi H, Makino A, Aoki A, Hodohara K, et al. Chylous ascites, anti-interferon-gamma autoantibody, and angioimmunoblastic T-cell lymphoma: a rare but intriguing connection over Mycobacterium avium. Med Microbiol Immunol. 2019;208:33–7.

Article  CAS  PubMed  Google Scholar 

Liu TT, Weng SW, Wang MC, Huang WT. Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy. APMIS. 2016;124:216–20.

Article  CAS  PubMed  Google Scholar 

Angkasekwinai N, Suputtamongkol Y, Phoompoung P, Pithukpakorn M, Wongswat E, Umrod P, et al. Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-γ autoantibodies. PLoS ONE. 2019;14:e0215581.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boyle S, Hagiya A, Nguyen MH, Liebman H, Lee JSG. The unique diagnostic and management challenge of a patient with concomitant anti-interferon-gamma autoantibody associated immunodeficiency syndrome, IgG4-related disease, and treatment refractory, disseminated mycobacterium avium complex infection. Allergy Asthma Clin Immunol. 2022;18:82.

Article  PubMed  PubMed Central  Google Scholar 

Namkoong H, Asakura T, Ishii M, Yoda S, Masaki K, Sakagami T, et al. First report of hepatobiliary infection developing obstructive jaundice in a patient with neutralizing anti-interferon-gamma autoantibodies. New Microbes New Infect. 2019;27:4–6.

Article  CAS  PubMed  Google Scholar 

King EM, Weaver VK, Kestler MH. Treatment dilemmas in disseminated nontuberculous mycobacterial infections with interferon-gamma autoantibodies. Open Forum Infect Dis. 2021;8:ofab253.

Article  PubMed  PubMed Central  Google Scholar 

Pruetpongpun N, Khawcharoenporn T, Damronglerd P, Suthiwartnarueput W, Apisarnthanarak A, Rujanavej S, et al. Disseminated Talaromyces marneffei and Mycobacterium abscessus in a patient with anti-interferon-γ autoantibodies. Open Forum Infect Dis. 2016;3:ofw093.

Article  PubMed  PubMed Central  Google Scholar 

Laisuan W, Pisitkun P, Ngamjanyaporn P, Suangtamai T, Rotjanapan P. Prospective Pilot Study of Cyclophosphamide as an Adjunct Treatment in Patients With Adult-Onset Immunodeficiency Associated With Anti-interferon-gamma Autoantibodies. Open Forum Infect Dis. 2020;7:ofaa035.

Article  PubMed  PubMed Central  Google Scholar 

Rocco JM, Rosen LB, Hong GH, Treat J, Zerbe CS. Bortezomib treatment for refractory nontuberculous mycobacterial infection in the setting of interferon gamma autoantibodies. J Transl Autoimmun. 2021;4:100102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeitler K, Walter J, Khan F, Sriaroon C. Recurrent disseminated Mycobacterium avium in a female patient from Thailand with anti-interferon-gamma autoantibodies: dilemma on treatment approach. BMJ Case Rep. 2021;14:e237909.

Article  PubMed  PubMed Central  Google Scholar 

Roerden M, Döffinger R, Barcenas-Morales G, Forchhammer S, Döbele S, Berg C. Simultaneous disseminated infections with intracellular pathogens: an intriguing case report of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies. BMC Infect Dis. 2020;20:828.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saba M, Greene JN. Refractory mycobacterium avium complex pneumonia and anti-interferon-gamma autoantibodies: a case report. Infect Dis Clin Pract. 2019;27:110–3.

Article  Google Scholar 

Daley AS, Naro GR, Craig TJ, Hussein RHA, Banjade R, Jacobs JB, et al. POPS case: a 30-year-old Filipino woman with fevers, lymphadenopathy, painful scalp lesions, and a neck mass. Allergy Asthma Proc. 2020;41:305–8.

Article  PubMed  Google Scholar 

Ochoa S, Ding L, Kreuzburg S, Treat J, Holland S, Zerbe C. Daratumumab (anti-CD38) for treatment of disseminated nontuberculous mycobacteria in a patient with anti-interferon-γ autoantibodies. Clin Infect Dis. 2021;72:2206–8.

Article  PubMed  Google Scholar 

Chetchotisakd P, Anunnatsiri S, Nanagara R, Nithichanon A, Lertmemongkolchai G. Intravenous cyclophosphamide therapy for anti-IFN-gamma autoantibody-associated infection. J Immunol Res. 2018;2018:6473629.

Article  PubMed  PubMed Central  Google Scholar 

Harada M, Furuhashi K, Karayama M, Suzuki Y, Hozumi H, Enomoto N, et al. Subcutaneous injection of interferon gamma therapy could be useful for anti-IFN-γ autoantibody associated disseminated nontuberculous mycobacterial infection. J Infect Chemother. 2021;27:373–8.

Article  CAS  PubMed  Google Scholar 

Kampmann B, Hemingway C, Stephens A, Davidson R, Goodsall A, Anderson S, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest. 2005;115:2480–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dahl V, Nielsen B, Wejse C, Marquart H, Bay J, von Stemann J, et al. Disseminated Mycobacterium avium complex infection in a woman with anti-interferon-γ autoantibodies. IDCases. 2021;26:e01300.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kacar M, Cortes-Acevedo P, Patel V, Carter C, Hughes P, McGann HP, et al. Neutralizing anti-interferon-gamma autoantibodies: an ameliorating factor in COVID-19 infection? J Clin Immunol. 2021;41:1531–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin F, Yang Z, Qiu Y, Zeng W, Liu G, Zhang J. Talaromyces Marneffei infection in lung cancer patients with positive AIGAs: a rare case report. Infect Drug Resist. 2021;14:5005–13.

Article  PubMed  PubMed Central  Google Scholar 

Hanitsch LG, Lobel M, Muller-Redetzky H, Schurmann M, Suttorp N, Unterwalder N, et al. Late-onset disseminated mycobacterium avium intracellulare complex infection (MAC), cerebral toxoplasmosis and salmonella sepsis in a German Caucasian patient with unusual anti-interferon-gamma IgG1 autoantibodies. J Clin Immunol. 2015;35:361–5.

Article  CAS  PubMed  Google Scholar 

Shih HP, Ding JY, Yeh CF, Chi CY, Ku CL. Anti-interferon-gamma autoantibody-associated immunodeficiency. Curr Opin Immunol. 2021;72:206–14.

Article  CAS 

留言 (0)

沒有登入
gif